Cargando…
Corrigendum: SCD1 Confers Temozolomide Resistance to Human Glioma Cells Via the Akt/GSK3β/β-Catenin Signaling Axis
Autores principales: | Dai, Shuang, Yan, Yuanliang, Xu, Zhijie, Zeng, Shuangshuang, Qian, Long, Huo, Lei, Li, Xuejun, Sun, Lunquan, Gong, Zhicheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6874015/ https://www.ncbi.nlm.nih.gov/pubmed/31798454 http://dx.doi.org/10.3389/fphar.2019.01358 |
Ejemplares similares
-
SCD1 Confers Temozolomide Resistance to Human Glioma Cells via the Akt/GSK3β/β-Catenin Signaling Axis
por: Dai, Shuang, et al.
Publicado: (2018) -
Targeting autophagy to sensitive glioma to temozolomide treatment
por: Yan, Yuanliang, et al.
Publicado: (2016) -
Novel Function of lncRNA ADAMTS9-AS2 in Promoting Temozolomide Resistance in Glioblastoma via Upregulating the FUS/MDM2 Ubiquitination Axis
por: Yan, Yuanliang, et al.
Publicado: (2019) -
An Insight into the Increasing Role of LncRNAs in the Pathogenesis of Gliomas
por: Yan, Yuanliang, et al.
Publicado: (2017) -
PCDH8 inhibits glioma cell proliferation by negatively regulating the AKT/GSK3β/β-catenin signaling pathway
por: Zong, Zhenkun, et al.
Publicado: (2017)